Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 287

1.

Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice.

Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G, Ishaku S; International Society for the Study of Hypertension in Pregnancy (ISSHP).

Hypertension. 2018 Jul;72(1):24-43. doi: 10.1161/HYPERTENSIONAHA.117.10803. Review. No abstract available.

PMID:
29899139
2.

A framework for healthcare interventions to address maternal morbidity.

Firoz T, McCaw-Binns A, Filippi V, Magee LA, Costa ML, Cecatti JG, Barreix M, Adanu R, Chou D, Say L; members of the WHO Maternal Morbidity Working Group (MMWG).

Int J Gynaecol Obstet. 2018 May;141 Suppl 1:61-68. doi: 10.1002/ijgo.12469. Review.

PMID:
29851114
3.

The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice.

Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G, Ishaku S; International Society for the Study of Hypertension in Pregnancy (ISSHP).

Pregnancy Hypertens. 2018 May 23. pii: S2210-7789(18)30126-0. doi: 10.1016/j.preghy.2018.05.004. [Epub ahead of print] Review. No abstract available.

PMID:
29803330
4.

Hypertension Canada's 2018 Guidelines for the Management of Hypertension in Pregnancy.

Butalia S, Audibert F, Côté AM, Firoz T, Logan AG, Magee LA, Mundle W, Rey E, Rabi DM, Daskalopoulou SS, Nerenberg KA; Hypertension Canada.

Can J Cardiol. 2018 May;34(5):526-531. doi: 10.1016/j.cjca.2018.02.021. Epub 2018 Mar 1.

PMID:
29731014
5.

Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.

Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Grégoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, Leiter LA, Jones C, Woo V, Hegele RA, Selby P, Pipe A, McFarlane PA, Oh P, Gupta M, Bacon SL, Kaczorowski J, Trudeau L, Campbell NRC, Hiremath S, Roerecke M, Arcand J, Ruzicka M, Prasad GVR, Vallée M, Edwards C, Sivapalan P, Penner SB, Fournier A, Benoit G, Feber J, Dionne J, Magee LA, Logan AG, Côté AM, Rey E, Firoz T, Kuyper LM, Gabor JY, Townsend RR, Rabi DM, Daskalopoulou SS; Hypertension Canada.

Can J Cardiol. 2018 May;34(5):506-525. doi: 10.1016/j.cjca.2018.02.022. Epub 2018 Mar 1.

PMID:
29731013
6.

Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study).

Pels A, Mol BWJ, Singer J, Lee T, von Dadelszen P, Ganzevoort W, Asztalos E, Magee LA; CHIPS Study Group.

Hypertension. 2018 Jun;71(6):1170-1177. doi: 10.1161/HYPERTENSIONAHA.117.10689. Epub 2018 Apr 23.

7.

Neurodevelopment of Infants with and without Craniofacial Microsomia.

Speltz ML, Kapp-Simon KA, Johns AL, Wallace ER, Collett BR, Magee L, Leroux BG, Luquetti DV, Heike CL.

J Pediatr. 2018 Apr 20. pii: S0022-3476(18)30339-1. doi: 10.1016/j.jpeds.2018.02.076. [Epub ahead of print]

PMID:
29685618
8.

Quality of Life in Adults with Nonsyndromic Craniosynostosis.

Mazzaferro DM, Naran S, Wes AM, Magee L, Taylor JA, Bartlett SP.

Plast Reconstr Surg. 2018 Jun;141(6):1474-1482. doi: 10.1097/PRS.0000000000004408.

PMID:
29579020
9.

Early diagnosis of preeclampsia using placental growth factor: An operational pilot study in Maputo, Mozambique.

Manriquez Rocha B, Mbofana F, Loquiha O, Mudenyanga C, Ukah UV, Magee LA, von Dadelszen P.

Pregnancy Hypertens. 2018 Jan;11:26-31. doi: 10.1016/j.preghy.2017.12.005. Epub 2017 Dec 24.

PMID:
29523269
10.

Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia.

Ukah UV, Payne B, Hutcheon JA, Ansermino JM, Ganzevoort W, Thangaratinam S, Magee LA, von Dadelszen P.

Hypertension. 2018 Apr;71(4):659-665. doi: 10.1161/HYPERTENSIONAHA.117.10318. Epub 2018 Feb 12.

11.

MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)-implementation of a national guideline in Canada.

De Silva DA, Synnes AR, von Dadelszen P, Lee T, Bone JN; MAG-CP, CPN and CNN collaborative groups, Magee LA.

Implement Sci. 2018 Jan 11;13(1):8. doi: 10.1186/s13012-017-0702-9.

12.

Determinants of magnesium sulphate use in women hospitalized at <29 weeks with severe or non-severe pre-eclampsia.

De Silva DA, Proctor L, von Dadelszen P, McCoach M, Lee T; Canadian Perinatal Network (CPN) Collaborative Group, Magee LA.

PLoS One. 2017 Dec 22;12(12):e0189966. doi: 10.1371/journal.pone.0189966. eCollection 2017.

13.

Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review.

Ukah UV, De Silva DA, Payne B, Magee LA, Hutcheon JA, Brown H, Ansermino JM, Lee T, von Dadelszen P.

Pregnancy Hypertens. 2018 Jan;11:115-123. doi: 10.1016/j.preghy.2017.11.006. Epub 2017 Nov 21. Review.

14.

Prevalence, risk factors and associated complications of postpartum hypertension in rural Haiti.

Kang E, Sugarman R, Ramadan H, Mueller A, Shahul S, Perdigao JL, Louis DJ, Narcisse R, Sannon H, Magee L, Rana S.

Pregnancy Hypertens. 2017 Oct;10:135-142. doi: 10.1016/j.preghy.2017.07.143. Epub 2017 Jul 25.

PMID:
29153666
15.

Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy: A Systematic Review.

Ukah UV, Hutcheon JA, Payne B, Haslam MD, Vatish M, Ansermino JM, Brown H, Magee LA, von Dadelszen P.

Hypertension. 2017 Dec;70(6):1228-1237. doi: 10.1161/HYPERTENSIONAHA.117.10150. Epub 2017 Oct 30. Review.

16.

Reverse innovation in maternal health.

Firoz T, Makanga PT, Nathan HL, Payne B, Magee LA.

Obstet Med. 2017 Sep;10(3):113-119. doi: 10.1177/1753495X17700515. Epub 2017 May 16.

PMID:
29051778
17.

The Difference Between Living and Dying: Victim Characteristics and Motive Among Nonfatal Shootings and Gun Homicides.

Hipple NK, Magee LA.

Violence Vict. 2017 Dec 1;32(6):977-997. doi: 10.1891/0886-6708.VV-D-16-00150. Epub 2017 Oct 10.

PMID:
29017638
18.

Timing of delivery in a high-risk obstetric population: a clinical prediction model.

De Silva DA, Lisonkova S, von Dadelszen P, Synnes AR; Canadian Perinatal Network (CPN) Collaborative Group, Magee LA.

BMC Pregnancy Childbirth. 2017 Jun 29;17(1):202. doi: 10.1186/s12884-017-1390-9.

19.

SOCIETAL PERSPECTIVE ON COST DRIVERS FOR HEALTH TECHNOLOGY ASSESSMENT IN SINDH, PAKISTAN.

Khowaja AR, Mitton C, Qureshi R, Bryan S, Magee LA, von Dadelszen P, Bhutta ZA.

Int J Technol Assess Health Care. 2017 Jan;33(2):192-198. doi: 10.1017/S0266462317000320. Epub 2017 Jun 7.

20.

Validating the Performance of the Modified Early Obstetric Warning System Multivariable Model to Predict Maternal Intensive Care Unit Admission.

Ryan HM, Jones MA, Payne BA, Sharma S, Hutfield AM, Lee T, Ukah UV, Walley KR, Magee LA, von Dadelszen P.

J Obstet Gynaecol Can. 2017 Sep;39(9):728-733.e3. doi: 10.1016/j.jogc.2017.01.028. Epub 2017 May 26.

Supplemental Content

Support Center